Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:41 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Daikaffil Chemicals India Ltd operates in the dyes and pigments industry, with its current share price standing at ₹121 and a market capitalization of ₹72.6 Cr. The company has experienced a significant decline in revenue, reporting sales of only ₹0.64 Cr for FY 2023, a stark contrast to ₹8.16 Cr in FY 2022. The sales figures over the last few quarters have shown a concerning trend, with a drop to ₹0.00 Cr in the first half of FY 2024. However, there is a noted increase in anticipated revenues, with ₹7.50 Cr projected for FY 2025, indicating a potential recovery. The operating profit margins have been negative, with an operating profit margin (OPM) of -10.25% as of the latest reporting. This decline in revenue raises questions about the company’s market positioning and demand for its products, particularly in a competitive sector where efficiency and profitability are critical for survival.
Profitability and Efficiency Metrics
In terms of profitability, Daikaffil Chemicals has struggled, as evidenced by its reported net profit of -₹2.41 Cr for FY 2023, down from -₹2.50 Cr in FY 2022. The negative net profit reflects ongoing operational challenges, leading to a return on equity (ROE) of 18.6% and a return on capital employed (ROCE) also at 18.6%. The company has maintained a relatively high interest coverage ratio of 188.00x, indicating a strong ability to cover interest expenses despite its negative profitability. However, the cash conversion cycle (CCC) stood at 215.26 days, suggesting inefficiencies in managing working capital. Furthermore, the operating profit has consistently been negative across multiple quarters, highlighting the need for operational improvements. The company’s OPM, which reached -10.25%, is indicative of the pressures it faces in maintaining cost control amidst declining revenues.
Balance Sheet Strength and Financial Ratios
Daikaffil Chemicals demonstrates a robust balance sheet with no borrowings, reflecting a conservative financial strategy. As of the latest reporting, reserves have dwindled to ₹2.85 Cr from ₹16.12 Cr in FY 2023, indicating a depletion of retained earnings, which could impact future investment capabilities. The company’s price-to-book value (P/BV) ratio is reported at 1.34x, suggesting that the stock is trading at a slight premium relative to its book value. This valuation might attract investors looking for undervalued stocks in a challenging market. However, the observed decline in total assets from ₹26.70 Cr in FY 2022 to ₹14.78 Cr in FY 2025 raises concerns about asset management and the overall financial health of the company. Additionally, the negative operating profit over recent periods reflects a challenging operational environment that may hinder financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Daikaffil Chemicals shows that promoters hold 52.64% of the company, indicating a strong insider commitment. However, foreign institutional investors (FIIs) are not reported, while domestic institutional investors (DIIs) have a negligible stake of 0.00%. The public holds 47.35%, reflecting a diverse investor base, albeit with limited institutional backing. The total number of shareholders has declined from 3,646 in September 2022 to 3,145 in June 2025, suggesting a reduction in investor confidence amid the company’s financial struggles. The gradual increase in promoter holding from 31.19% in September 2022 to the current level indicates a strategic move to consolidate ownership in response to market conditions. This consolidation could signal confidence in a turnaround strategy, but the absence of institutional support may raise concerns regarding liquidity and market perception.
Outlook, Risks, and Final Insight
The outlook for Daikaffil Chemicals appears mixed, with potential for recovery as indicated by the anticipated sales of ₹7.50 Cr in FY 2025. However, the company faces significant risks, including operational inefficiencies reflected in the negative OPM and CCC metrics. The high dependence on promoter holding without institutional backing may limit the company’s agility in responding to market changes. Furthermore, the ongoing depletion of reserves poses a threat to its financial flexibility. Conversely, the absence of debt provides a cushion against financial distress, allowing the company to explore strategic partnerships or operational restructuring. The key to future success lies in enhancing operational efficiency, restoring profitability, and possibly attracting institutional investment to bolster financial stability and growth initiatives.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Daikaffil Chemicals India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 41.9 Cr. | 138 | 190/68.5 | 23.0 | 162 | 0.72 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 53.6 Cr. | 89.3 | 281/87.4 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 834 Cr. | 675 | 1,148/408 | 21.5 | 91.7 | 0.15 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,871 Cr. | 375 | 572/314 | 38.9 | 62.2 | 1.33 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 54.8 Cr. | 48.8 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,395.92 Cr | 312.11 | 101.70 | 186.43 | 0.37% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.30 | 0.63 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.50 | 4.00 |
| Expenses | 1.46 | 1.29 | 0.43 | 0.43 | 0.40 | 0.40 | 0.29 | 0.25 | 1.31 | 0.44 | 0.90 | 3.55 | 4.41 |
| Operating Profit | -0.16 | -0.66 | -0.42 | -0.43 | -0.40 | -0.40 | -0.29 | -0.25 | -1.31 | -0.44 | -0.90 | -0.05 | -0.41 |
| OPM % | -12.31% | -104.76% | -4,200.00% | -1.43% | -10.25% | ||||||||
| Other Income | 0.16 | 0.13 | 0.13 | 0.10 | 0.11 | 0.17 | 0.23 | 0.15 | 0.16 | 0.10 | 0.09 | 0.07 | 0.21 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.30 | 0.18 | 0.18 | 0.55 | 0.23 | 0.22 | 0.22 | -0.32 | 0.07 | 0.06 | 0.06 | 0.08 |
| Profit before tax | -0.29 | -0.84 | -0.47 | -0.51 | -0.84 | -0.46 | -0.28 | -0.32 | -0.83 | -0.41 | -0.87 | -0.04 | -0.28 |
| Tax % | -17.24% | -1.19% | 2.13% | -9.80% | -26.19% | -4.35% | -14.29% | -12.50% | 13.25% | -26.83% | -33.33% | 775.00% | 25.00% |
| Net Profit | -0.25 | -0.84 | -0.48 | -0.47 | -0.62 | -0.43 | -0.24 | -0.28 | -0.95 | -0.30 | -0.58 | -0.36 | -0.35 |
| EPS in Rs | -0.42 | -1.40 | -0.80 | -0.78 | -1.03 | -0.72 | -0.40 | -0.47 | -1.58 | -0.50 | -0.97 | -0.60 | -0.58 |
Last Updated: May 31, 2025, 6:23 am
Below is a detailed analysis of the quarterly data for Daikaffil Chemicals India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.50 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 0.50 Cr..
- For Expenses, as of Mar 2025, the value is 4.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.55 Cr. (Dec 2024) to 4.41 Cr., marking an increase of 0.86 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.41 Cr.. The value appears to be declining and may need further review. It has decreased from -0.05 Cr. (Dec 2024) to -0.41 Cr., marking a decrease of 0.36 Cr..
- For OPM %, as of Mar 2025, the value is -10.25%. The value appears to be declining and may need further review. It has decreased from -1.43% (Dec 2024) to -10.25%, marking a decrease of 8.82%.
- For Other Income, as of Mar 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Dec 2024) to 0.21 Cr., marking an increase of 0.14 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Dec 2024) to 0.08 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is -0.28 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Dec 2024) to -0.28 Cr., marking a decrease of 0.24 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 775.00% (Dec 2024) to 25.00%, marking a decrease of 750.00%.
- For Net Profit, as of Mar 2025, the value is -0.35 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Dec 2024) to -0.35 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.58. The value appears strong and on an upward trend. It has increased from -0.60 (Dec 2024) to -0.58, marking an increase of 0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.28 | 34.35 | 27.41 | 26.44 | 22.82 | 16.84 | 15.72 | 11.40 | 8.16 | 0.64 | 0.00 | 7.50 | 17.42 |
| Expenses | 30.31 | 31.36 | 24.24 | 21.77 | 19.53 | 15.04 | 13.88 | 11.23 | 10.20 | 2.55 | 2.25 | 9.29 | 18.63 |
| Operating Profit | 2.97 | 2.99 | 3.17 | 4.67 | 3.29 | 1.80 | 1.84 | 0.17 | -2.04 | -1.91 | -2.25 | -1.79 | -1.21 |
| OPM % | 8.92% | 8.70% | 11.57% | 17.66% | 14.42% | 10.69% | 11.70% | 1.49% | -25.00% | -298.44% | -23.87% | -6.95% | |
| Other Income | 0.29 | -0.16 | 0.55 | 0.55 | 0.85 | 0.42 | 0.85 | 0.55 | 0.47 | 0.47 | 0.71 | 0.47 | 0.30 |
| Interest | 0.36 | 0.26 | 0.14 | 0.07 | 0.05 | 0.03 | 0.07 | 0.05 | 0.03 | 0.01 | 0.00 | 0.01 | 0.01 |
| Depreciation | 0.61 | 0.42 | 0.40 | 1.48 | 0.97 | 0.96 | 1.12 | 1.12 | 1.13 | 1.21 | 0.35 | 0.27 | 0.32 |
| Profit before tax | 2.29 | 2.15 | 3.18 | 3.67 | 3.12 | 1.23 | 1.50 | -0.45 | -2.73 | -2.66 | -1.89 | -1.60 | -1.24 |
| Tax % | 37.55% | 27.91% | 33.96% | 33.51% | 23.40% | 29.27% | 28.00% | -11.11% | -8.42% | -9.77% | 0.53% | -0.62% | |
| Net Profit | 1.44 | 1.55 | 2.10 | 2.44 | 2.40 | 0.86 | 1.08 | -0.41 | -2.50 | -2.41 | -1.90 | -1.59 | -1.63 |
| EPS in Rs | 2.40 | 2.58 | 3.50 | 4.07 | 4.00 | 1.43 | 1.80 | -0.68 | -4.17 | -4.02 | -3.17 | -2.65 | -2.71 |
| Dividend Payout % | 33.33% | 30.97% | 28.57% | 41.80% | 30.00% | 0.00% | 38.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.64% | 35.48% | 16.19% | -1.64% | -64.17% | 25.58% | -137.96% | -509.76% | 3.60% | 21.16% | 16.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.84% | -19.29% | -17.83% | -62.53% | 89.75% | -163.54% | -371.79% | 513.36% | 17.56% | -4.85% |
Daikaffil Chemicals India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -14% |
| 3 Years: | -3% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 39% |
| 3 Years: | 90% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -13% |
| Last Year: | -19% |
Last Updated: September 5, 2025, 3:06 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.22 | 72.36 | 93.48 | 40.03 | 74.22 | 60.26 | 45.04 | 28.82 | 6.26 | 0.00 | 294.92 | |
| Inventory Days | 93.77 | 70.49 | 81.93 | 82.17 | 84.50 | 122.29 | 133.94 | 154.33 | 124.16 | 1,116.90 | 261.44 | |
| Days Payable | 132.45 | 85.28 | 69.49 | 34.20 | 80.69 | 39.27 | 80.53 | 59.90 | 7.49 | 21.90 | 341.10 | |
| Cash Conversion Cycle | 54.55 | 57.57 | 105.91 | 88.00 | 78.03 | 143.28 | 98.46 | 123.24 | 122.94 | 1,095.00 | 215.26 | |
| Working Capital Days | 46.17 | 47.71 | 83.63 | 76.89 | 93.25 | 113.14 | 73.37 | 99.89 | 108.25 | 4,956.02 | 279.35 | |
| ROCE % | 21.18% | 18.76% | 25.06% | 19.85% | 12.70% | 4.94% | 5.99% | -1.51% | -10.58% | -11.27% | -12.19% | -18.57% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Diluted EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Cash EPS (Rs.) | 5.56 | 6.55 | 4.18 | 3.26 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 20.89 | 18.57 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 21.30 | 18.99 | 0.00 |
| Revenue From Operations / Share (Rs.) | 38.02 | 44.06 | 45.74 | 57.54 | 0.00 |
| PBDIT / Share (Rs.) | 6.81 | 8.64 | 6.13 | 4.65 | 0.00 |
| PBIT / Share (Rs.) | 5.20 | 6.17 | 5.47 | 3.96 | 0.00 |
| PBT / Share (Rs.) | 5.17 | 6.14 | 5.31 | 3.61 | 0.00 |
| Net Profit / Share (Rs.) | 3.95 | 4.08 | 3.52 | 2.57 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 3.99 | 4.07 | 3.51 | 2.58 | 0.00 |
| PBDIT Margin (%) | 17.91 | 19.61 | 13.41 | 8.08 | 9.24 |
| PBIT Margin (%) | 13.68 | 14.01 | 11.96 | 6.87 | 7.44 |
| PBT Margin (%) | 13.58 | 13.92 | 11.61 | 6.27 | 6.54 |
| Net Profit Margin (%) | 10.39 | 9.26 | 7.69 | 4.46 | 4.02 |
| NP After MI And SOA Margin (%) | 10.48 | 9.24 | 7.66 | 4.49 | 4.21 |
| Return on Networth / Equity (%) | 9.37 | 10.02 | 17.03 | 14.13 | 0.00 |
| Return on Capital Employeed (%) | 11.66 | 14.30 | 24.61 | 20.13 | 0.00 |
| Return On Assets (%) | 7.86 | 8.76 | 11.04 | 7.69 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.17 | 0.00 |
| Asset Turnover Ratio (%) | 0.78 | 1.13 | 1.41 | 0.00 | 0.00 |
| Current Ratio (X) | 3.64 | 6.15 | 2.33 | 1.75 | 0.00 |
| Quick Ratio (X) | 2.79 | 4.42 | 1.63 | 1.22 | 0.00 |
| Inventory Turnover Ratio (X) | 4.00 | 3.91 | 3.90 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 51.29 | 29.57 | 28.51 | 30.94 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 36.54 | 18.41 | 23.98 | 24.38 | 0.00 |
| Earning Retention Ratio (%) | 48.71 | 70.43 | 71.49 | 69.06 | 0.00 |
| Cash Earning Retention Ratio (%) | 63.46 | 81.59 | 76.02 | 75.62 | 0.00 |
| Interest Coverage Ratio (X) | 188.00 | 227.77 | 38.19 | 13.38 | 8.22 |
| Interest Coverage Ratio (Post Tax) (X) | 110.03 | 108.62 | 22.92 | 8.48 | 5.44 |
| Enterprise Value (Cr.) | 30.57 | 33.78 | 15.30 | 14.48 | 0.00 |
| EV / Net Operating Revenue (X) | 1.34 | 1.28 | 0.55 | 0.41 | 0.00 |
| EV / EBITDA (X) | 7.48 | 6.51 | 4.16 | 5.18 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| Retention Ratios (%) | 48.70 | 70.42 | 71.48 | 69.05 | 0.00 |
| Price / BV (X) | 1.34 | 1.57 | 1.27 | 1.29 | 0.00 |
| Price / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| EarningsYield | 0.07 | 0.06 | 0.13 | 0.10 | 0.00 |
After reviewing the key financial ratios for Daikaffil Chemicals India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Diluted EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Cash EPS (Rs.), as of Mar 18, the value is 5.56. This value is within the healthy range. It has decreased from 6.55 (Mar 17) to 5.56, marking a decrease of 0.99.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 38.02. It has decreased from 44.06 (Mar 17) to 38.02, marking a decrease of 6.04.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 6.81. This value is within the healthy range. It has decreased from 8.64 (Mar 17) to 6.81, marking a decrease of 1.83.
- For PBIT / Share (Rs.), as of Mar 18, the value is 5.20. This value is within the healthy range. It has decreased from 6.17 (Mar 17) to 5.20, marking a decrease of 0.97.
- For PBT / Share (Rs.), as of Mar 18, the value is 5.17. This value is within the healthy range. It has decreased from 6.14 (Mar 17) to 5.17, marking a decrease of 0.97.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 3.95. This value is within the healthy range. It has decreased from 4.08 (Mar 17) to 3.95, marking a decrease of 0.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 3.99. This value is within the healthy range. It has decreased from 4.07 (Mar 17) to 3.99, marking a decrease of 0.08.
- For PBDIT Margin (%), as of Mar 18, the value is 17.91. This value is within the healthy range. It has decreased from 19.61 (Mar 17) to 17.91, marking a decrease of 1.70.
- For PBIT Margin (%), as of Mar 18, the value is 13.68. This value is within the healthy range. It has decreased from 14.01 (Mar 17) to 13.68, marking a decrease of 0.33.
- For PBT Margin (%), as of Mar 18, the value is 13.58. This value is within the healthy range. It has decreased from 13.92 (Mar 17) to 13.58, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 18, the value is 10.39. This value exceeds the healthy maximum of 10. It has increased from 9.26 (Mar 17) to 10.39, marking an increase of 1.13.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 10.48. This value is within the healthy range. It has increased from 9.24 (Mar 17) to 10.48, marking an increase of 1.24.
- For Return on Networth / Equity (%), as of Mar 18, the value is 9.37. This value is below the healthy minimum of 15. It has decreased from 10.02 (Mar 17) to 9.37, marking a decrease of 0.65.
- For Return on Capital Employeed (%), as of Mar 18, the value is 11.66. This value is within the healthy range. It has decreased from 14.30 (Mar 17) to 11.66, marking a decrease of 2.64.
- For Return On Assets (%), as of Mar 18, the value is 7.86. This value is within the healthy range. It has decreased from 8.76 (Mar 17) to 7.86, marking a decrease of 0.90.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.78. It has decreased from 1.13 (Mar 17) to 0.78, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 18, the value is 3.64. This value exceeds the healthy maximum of 3. It has decreased from 6.15 (Mar 17) to 3.64, marking a decrease of 2.51.
- For Quick Ratio (X), as of Mar 18, the value is 2.79. This value exceeds the healthy maximum of 2. It has decreased from 4.42 (Mar 17) to 2.79, marking a decrease of 1.63.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 4.00. This value is within the healthy range. It has increased from 3.91 (Mar 17) to 4.00, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 51.29. This value exceeds the healthy maximum of 50. It has increased from 29.57 (Mar 17) to 51.29, marking an increase of 21.72.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 36.54. This value is within the healthy range. It has increased from 18.41 (Mar 17) to 36.54, marking an increase of 18.13.
- For Earning Retention Ratio (%), as of Mar 18, the value is 48.71. This value is within the healthy range. It has decreased from 70.43 (Mar 17) to 48.71, marking a decrease of 21.72.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 63.46. This value is within the healthy range. It has decreased from 81.59 (Mar 17) to 63.46, marking a decrease of 18.13.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 188.00. This value is within the healthy range. It has decreased from 227.77 (Mar 17) to 188.00, marking a decrease of 39.77.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 110.03. This value is within the healthy range. It has increased from 108.62 (Mar 17) to 110.03, marking an increase of 1.41.
- For Enterprise Value (Cr.), as of Mar 18, the value is 30.57. It has decreased from 33.78 (Mar 17) to 30.57, marking a decrease of 3.21.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has increased from 1.28 (Mar 17) to 1.34, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 18, the value is 7.48. This value is within the healthy range. It has increased from 6.51 (Mar 17) to 7.48, marking an increase of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For Retention Ratios (%), as of Mar 18, the value is 48.70. This value is within the healthy range. It has decreased from 70.42 (Mar 17) to 48.70, marking a decrease of 21.72.
- For Price / BV (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has decreased from 1.57 (Mar 17) to 1.34, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For EarningsYield, as of Mar 18, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 17) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Daikaffil Chemicals India Ltd:
- Net Profit Margin: 10.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.66% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.37% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 110.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.79
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 101.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Plot No. E/4, M.I.D.C, Tarapur, Palghar District Maharashtra 401506 | cs@daikaffil.com http://www.daikaffil.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sadashiv K Shetty | Chairman |
| Mr. Raghuram K Shetty | Managing Director |
| Mr. Omprakash Singh | Independent Director |
| Mrs. Bhagavati Kalpesh Donga | Independent Director |